Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Assets Average (2016 - 2025)

Historic Assets Average for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $1.6 billion.

  • Collegium Pharmaceutical's Assets Average rose 1902.21% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1902.21%. This contributed to the annual value of $1.4 billion for FY2024, which is 2112.07% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Assets Average of $1.6 billion as of Q3 2025, which was up 1902.21% from $1.6 billion recorded in Q2 2025.
  • Collegium Pharmaceutical's 5-year Assets Average high stood at $1.6 billion for Q4 2024, and its period low was $645.0 million during Q1 2021.
  • Moreover, its 5-year median value for Assets Average was $1.2 billion (2023), whereas its average is $1.2 billion.
  • In the last 5 years, Collegium Pharmaceutical's Assets Average skyrocketed by 8324.13% in 2022 and then crashed by 1073.11% in 2024.
  • Quarter analysis of 5 years shows Collegium Pharmaceutical's Assets Average stood at $716.9 million in 2021, then surged by 65.64% to $1.2 billion in 2022, then dropped by 2.28% to $1.2 billion in 2023, then surged by 42.13% to $1.6 billion in 2024, then decreased by 2.99% to $1.6 billion in 2025.
  • Its Assets Average was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.6 billion in Q1 2025.